IL33 and inflammatory bowel disease: IL-33 has been implicated in chronic inflammatory diseases of the gastrointestinal tract where fibrosis has a pathogenic role, such as eosinophilic oesophagitis (EoE) and inflammatory bowel disease (IBD).